SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001104659-24-083039
Filing Date
2024-07-26
Accepted
2024-07-26 16:31:18
Documents
1
Period of Report
2024-07-24

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm2420254-1_4seq1.html 4  
1 OWNERSHIP DOCUMENT tm2420254-1_4seq1.xml 4 7104
  Complete submission text file 0001104659-24-083039.txt   8796
Mailing Address 7707 GATEWAY BLVD., SUITE 140 NEWARK CA 94560-1160
Business Address 7707 GATEWAY BLVD., SUITE 140 NEWARK CA 94560-1160 (510) 474-0170
Protagonist Therapeutics, Inc (Issuer) CIK: 0001377121 (see all company filings)

IRS No.: 980505495 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O CALITHERA BIOSCIENCES 343 OYSTER POINT BLVD, SUITE 200 SO. SAN FRANCISCO CA 94080
Business Address
Waddill William D. (Reporting) CIK: 0001553338 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37852 | Film No.: 241147400